Duplilumab

Indications

Asthma (see Asthma, [[Asthma]])

  • Indications
    • Peripheral Eosinophilia: ≥300 cells/uL
    • Sputum Eosinophilia: ≥3%
    • Symptoms Not Well-Controlled on Medium-High Dose Inhaled Corticosteroids and Long-Acting Beta Agonist (LABA)
  • Clinical Efficacy
    • xxxx

Pharmacology

  • Fully Human Monoclonal Antibody Which Binds to Alpha Subunit of Interleukin-4 (IL-4) Rceeptor

Metabolism

  • xxxx

Administration

  • xxxx

Dose Adjustment

  • Hepatic:
  • Renal:

Adverse Effects

Other Adverse Effects

  • xxx
  • xxx
  • xxx

References

  • xxxx